Saint Paul's Hospital Millennium Medical College
Addis Ababa, 1271, Ethiopia
NCT Number: NCT04602052
The purpose of the study is to determine the safety and effectiveness of dilation and evacuation for surgical abortion as compared to medical abortion
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Addis Ababa, 1271, Ethiopia
All patients with a gestational age between 13-20 weeks are fully counseled on the risks and benefits and given the option of medical or surgical abortion. Those who choose medical abortion receive mifepristone 200 mg on day 1 and are appointed to return to SPHMMC 24-48 hours later for admission and misoprostol administration. Those who chose surgical abortion are given mifepristone 200 mg with or without laminaria and appointed to return the next day for surgical abortion.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Abortion is termination of pregannacy by evaccuating the uterus using either medical or surgical technique
Other names: Medical abortion
Time frame: During the abortion procedure and within 2 weeks post procedure
Presence of one of the following complications: bleeding requiring observation, genital tract lacerations requiring repair, need for additional intervention to complete the abortion procedure, and one or more symptoms of pelvic infection
Time frame: During the abortion procedure and within 2 weeks post procedure
Continued bleeding for more than two weeks, additional major surgery (laparotomy), and death.
St. Paul's Hospital Millennium Medical College, Ethiopia
Other
Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia: A Quasi-experimental Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03802149
Dilatation, Pathologic, Pathological Conditions, Anatomical
Stanford, California, United States
View Trial DetailsNCT07604051
Termination of Pregnancy
Faisalabad, Punjab Province, Pakistan
View Trial DetailsNCT02597699
Feticide, Termination of Pregnancy
Montpellier, France
View Trial DetailsNCT04910958
COVID-19, Coronaviridae Infections
Hadera, Israel
View Trial Details